| Antibody Structure and Function: The Basis for Engineering Therapeutics ML Chiu, DR Goulet, A Teplyakov, GL Gilliland Antibodies 8 (4), 55, 2019 | 669 | 2019 |
| Considerations for the design of antibody-based therapeutics DR Goulet, WM Atkins Journal of pharmaceutical sciences 109 (1), 74-103, 2020 | 284 | 2020 |
| Rapid purification of human bispecific antibodies via selective modulation of protein a binding A Zwolak, CN Leettola, SH Tam, DR Goulet, MG Derebe, JR Pardinas, ... Scientific reports 7 (1), 1-11, 2017 | 33 | 2017 |
| ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern TI Tsai, JS Khalili, M Gilchrist, AB Waight, D Cohen, S Zhuo, Y Zhang, ... Antiviral research, 105271, 2022 | 19 | 2022 |
| Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance DR Goulet, MJ Watson, SH Tam, A Zwolak, ML Chiu, WM Atkins, A Nath Drug Metabolism and Disposition 46 (12), 1900-1907, 2018 | 17 | 2018 |
| Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies DR Goulet, SJ Orcutt, A Zwolak, T Rispens, AF Labrijn, RN de Jong, ... Journal of Biological Chemistry 293 (2), 651-661, 2018 | 15 | 2018 |
| Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability DR Goulet, S Chatterjee, WP Lee, AB Waight, Y Zhu, ANS Mak Antibodies 11 (1), 6, 2022 | 11 | 2022 |
| Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors DR Goulet, A Zwolak, JA Williams, ML Chiu, WM Atkins Proteins: Structure, Function, and Bioinformatics 88 (5), 689-697, 2020 | 10 | 2020 |
| Codon Optimization Using a Recurrent Neural Network DR Goulet, Y Yan, P Agrawal, AB Waight, AN Mak, Y Zhu Journal of Computational Biology, 2022 | 9 | 2022 |
| Modulation of protein A binding allows single-step purification of mouse bispecific antibodies that retain FcRn binding A Zwolak, AA Armstrong, SH Tam, JR Pardinas, DR Goulet, S Zheng, ... MAbs 9 (8), 1306-1316, 2017 | 9 | 2017 |
| Diffusion of Soluble Aggregates of THIOMABs and Bispecific Antibodies in Serum DR Goulet, A Zwolak, ML Chiu, A Nath, WM Atkins Biochemistry 56 (17), 2251-2260, 2017 | 2 | 2017 |
| Miniature guidance and navigation control (miniGNC) antibody-like proteins and methods of making and using thereof Y Zhu, S Chatterjee, DR Goulet, TI Tsai, B Renshaw, CG Vincent, ... WO Patent WO2021188736A1, 2021 | 1 | 2021 |
| Biepitopic tetravalent antibody targeting EGFR LA Helgeson, TC Rozanitis, DR Goulet, J Khalili, NS Davis, Y Zhu WO Patent WO2024050439A2, 2024 | | 2024 |
| Bispecific tetravalent antibody targeting EGFR and HER3 DR Goulet, J Khalili, NSA Mak, B Renshaw, H Zhu, Y Zhu WO Patent WO2023028548A2, 2023 | | 2023 |
| EGFR binding complex and method of making and using thereof DR Goulet, NSA Mak, H Zhu, Y Zhu WO Patent WO2022061256A2, 2022 | | 2022 |
| Recombinant ACE2-Fc fusion molecules and methods of making and using thereof TI Tsai, DR Goulet, NSA Mak, A Waight, SK Lundy, M Gilchrist, J Khalili, ... WO Patent WO2022072757A1, 2022 | | 2022 |
| Specificity enchanced bispecific antibody (SEBA) DR Goulet, TI Tsai, J Khalili, NSA Mak, H Zhu, Y Zhu WO Patent WO2022061255A1, 2022 | | 2022 |
| Guidance and navigation control (GNC) antibody-like proteins and methods of making and using thereof Y Zhu, DR Goulet, TI Tsai, S Chatterjee, B Renshaw, CG Vincent, ... WO Patent WO2021188737A1, 2021 | | 2021 |
| Anti-CD19 antibodies and methods of using and making thereof S Chatterjee, DR Goulet, A Waight, NSA Mak, J Khalili, Y Zhu WO Patent WO2021178253A1, 2021 | | 2021 |
| Guidance and navigation control proteins and method of making and using thereof DR Goulet, S Chatterjee, TI Tsai, B Renshaw, A Waight, NSA Mak, Y Zhu WO Patent WO2021092266A1, 2021 | | 2021 |
